Skip to content
Open access

Short-Term Changes in General and Central Adiposity and Subsequent Cardiometabolic Risk in Japanese Adults Undergoing Routine Health Screening.

Sep 2026 · Diabetes, obesity and metabolism · 0 citations · 30 references
Medicine

TL;DR

Increases in BMI and WHtR were consistently associated with higher risks of hypertension, dyslipidemia, hyperuricemia, hyperuricemia, and early CKM stage progression across baseline body size categories.

Abstract

Objective

Annual health screening provides repeated measurements of body mass index (BMI) and waist-based indices, but the implications of short-term changes in general and central adiposity for cardiometabolic risk remain unclear. We examined whether 1-year changes in BMI and waist-to-height ratio (WHtR) were associated with subsequent cardiometabolic outcomes and cardiovascular-kidney-metabolic (CKM) syndrome progression.

Methods

We analysed longitudinal health examination data from 144 394 Japanese employees aged 40-74 years between 2008 and 2023. One-year changes in BMI and WHtR were calculated from two consecutive annual examinations, and outcomes were assessed during the following year. Outcomes included incident hypertension, dyslipidemia, hyperuricemia, diabetes, major adverse cardiovascular events, all-cause mortality, and CKM stage progression. Pooled logistic regression with natural cubic splines was used to assess nonlinear associations, with analyses stratified by baseline BMI or WHtR quartiles.

Results

Increases in BMI and WHtR were consistently associated with higher risks of hypertension, dyslipidemia, hyperuricemia, and early CKM stage progression across baseline body size categories. For diabetes, increases in BMI and WHtR were associated with higher risk, whereas decreases were also associated with higher risk among leaner individuals. Associations with major adverse cardiovascular events were generally U-shaped. BMI loss was associated with higher mortality odds, although estimates were imprecise and potentially affected by reverse causation.

Conclusions

One-year changes in BMI and WHtR were associated with subsequent cardiometabolic risk and CKM stage progression. Anthropometric changes, particularly weight loss, may serve as signals for further assessment rather than causal determinants of risk.

Read PDF

Similar papers

Review Open access Sep 2026

Midlife BMI and A Body Shape Index in relation to mortality and coronary heart disease events in a nationwide cohort

Background Obesity is a known cardiovascular risk factor. A Body Shape Index (ABSI) is a waist circumference (WC)-based measure of abdominal obesity, independent of Body Mass Index (BMI). We examined the independent and joint associations of ABSI and BMI with long-term mortality and coronary heart disease (CHD) events...

I. Shafran, N. Krakauer, J. Krakauer et al. · 0 citations
Aug 2026

Quantifying the cardiometabolic burden of increasing BMI: associations with blood pressure, lipids, glucose, insulin resistance, atherogenic dyslipidemia, and metabolic syndrome in Spanish workers

increasing BMI is associated with a substantial and progressive cardiometabolic burden characterized by worsening blood pressure, glucose metabolism, insulin resistance, lipid abnormalities, atherogenic dyslipidemia, and metabolic syndrome, highlighting the importance of early prevention and weight-management strategie...

Alberto Ramírez-Gallegos, Margarita Isabel Moyá-Seguí, Mari Carmen Gallegos-Álvarez et al. · 0 citations
Review Open access Aug 2026

Reassessment-stage metabolic indices and subsequent cardiorenal outcomes in adults with diabetes: CHARLS and an independent hospital validation cohort

Background Simple metabolic indices may capture residual cardiorenal risk beyond conventional glycemic markers, but their reassessment-stage value and external reproducibility remain unclear. We evaluated the triglyceride-glucose (TyG) index, metabolic score for insulin resistance (METS-IR), triglyceride total choleste...

Ming-Liang Liu, Yan Kong, Shi-Hang Chen et al. · 0 citations
Open access Sep 2026

Predictive value of baseline, cumulative exposure and annual mean changes in TyG-related indices for cardiovascular events in older rural adults with cardiovascular-kidney-metabolic syndrome stages 0–3: a cohort study

Background The triglyceride-glucose (TyG) index and its derivatives are cost-effective markers of insulin resistance and cardiovascular risk. However, the comparative predictive value of baseline levels, cumulative exposure, and annual mean changes in TyG-related indices remains unclear. This study aimed to systematica...

Yang-Zhen Xue, Qing-Xiu Tian, Rong Zhang et al. · 0 citations
Open access Aug 2026

Short- and long-term associations of insulin resistance indices with cardiovascular–kidney–metabolic syndrome risk: a retrospective cohort study

The METS-IR, TyG-BMI, and SPISE showed robust nonlinear associations with CKM syndrome risk and were stronger in males, supporting their potential value in sex-tailored risk assessment.

Hui Luo, Xue-Ting Wang, Cheng Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.